IE45773B1 - 11-deoxy-11-oxaprostaglandin compounds - Google Patents

11-deoxy-11-oxaprostaglandin compounds

Info

Publication number
IE45773B1
IE45773B1 IE1889/77A IE188977A IE45773B1 IE 45773 B1 IE45773 B1 IE 45773B1 IE 1889/77 A IE1889/77 A IE 1889/77A IE 188977 A IE188977 A IE 188977A IE 45773 B1 IE45773 B1 IE 45773B1
Authority
IE
Ireland
Prior art keywords
hydroxy
acid
trans
deoxy
tetranor
Prior art date
Application number
IE1889/77A
Other languages
English (en)
Other versions
IE45773L (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IE45773L publication Critical patent/IE45773L/xx
Publication of IE45773B1 publication Critical patent/IE45773B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Manipulator (AREA)
IE1889/77A 1976-09-15 1977-09-14 11-deoxy-11-oxaprostaglandin compounds IE45773B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72360476A 1976-09-15 1976-09-15

Publications (2)

Publication Number Publication Date
IE45773L IE45773L (en) 1978-03-15
IE45773B1 true IE45773B1 (en) 1982-11-17

Family

ID=24906946

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1889/77A IE45773B1 (en) 1976-09-15 1977-09-14 11-deoxy-11-oxaprostaglandin compounds

Country Status (9)

Country Link
JP (1) JPS5337653A (fr)
BE (1) BE858682A (fr)
DE (1) DE2739277C2 (fr)
DK (1) DK408377A (fr)
FR (1) FR2364912A1 (fr)
GB (1) GB1539364A (fr)
IE (1) IE45773B1 (fr)
LU (1) LU78116A1 (fr)
NL (1) NL169739C (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337254A (en) 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
JPS5915198A (ja) * 1982-07-15 1984-01-26 石川島播磨重工業株式会社 シ−ルド掘進機
JPS5927846U (ja) * 1982-08-13 1984-02-21 日本ワグナ−・スプレ−テツク株式会社 空圧制御式スプレ−ガン
JPS59210190A (ja) * 1983-05-11 1984-11-28 大和技建株式会社 圧気シ−ルド推進工法
JPS60112414U (ja) * 1984-01-06 1985-07-30 大阪機工株式会社 液体充填用紙製容器の注出栓
JPH041058Y2 (fr) * 1985-09-30 1992-01-14
JPH041056Y2 (fr) * 1985-09-30 1992-01-14
US5814660A (en) * 1995-12-22 1998-09-29 Alcon Laboratories, Inc. 9-oxa prostaglandin analogs as ocular hypotensives
ATE273009T1 (de) 1995-12-22 2004-08-15 Alcon Lab Inc Substituierte tetrahydrofuran-analoge von prostaglandinen als augendrucksenkende mittel
US5866602A (en) * 1995-12-22 1999-02-02 Alcon Laboratories, Inc. Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives

Also Published As

Publication number Publication date
JPS5337653A (en) 1978-04-06
DE2739277C2 (de) 1982-06-09
NL169739B (nl) 1982-03-16
BE858682A (fr) 1978-03-14
LU78116A1 (fr) 1979-05-23
NL169739C (nl) 1982-08-16
FR2364912A1 (fr) 1978-04-14
FR2364912B1 (fr) 1980-10-03
IE45773L (en) 1978-03-15
DE2739277A1 (de) 1978-03-16
DK408377A (da) 1978-03-16
JPS5755719B2 (fr) 1982-11-25
GB1539364A (en) 1979-01-31
NL7710065A (nl) 1978-03-17

Similar Documents

Publication Publication Date Title
US4087604A (en) Substituted ω-pentanorprostaglandins
IE42937B1 (en) 2-descarboxy-2-(tetrazol-5-y6)-11-desoxy-15-substituted-w-pentanorprostaglandins
US4035414A (en) Prostanoic acid derivatives
FI58912B (fi) Analogifoerfarande foer framstaellning av nya terapeutiskt aktiva foereningar tillhoerande prostaglandinserierna e och f
US4152527A (en) 15-Substituted-ω-pentanorprostaglandins
US4169895A (en) Antisecretory 16,16-dimethyl-17-oxaprostaglandins
IE45773B1 (en) 11-deoxy-11-oxaprostaglandin compounds
US4004020A (en) Novel prostanoic acid derivatives and process for the preparation thereof
CH619930A5 (fr)
US3984424A (en) P-biphenyl esters of 15-substituted-ω-pentanorprostaglandins
HU181424B (en) Process for preparing omega-nor-aromatic-13,14-dehydro-prostaglandins
US4361577A (en) ω-Nor-cycloalkyl-13,14-dehydro-prostaglandins and process for their preparation
US4154949A (en) 11-Desoxy-15-substituted-ω-pentanor prostaglandins
US4089896A (en) 8,12-Diisoprostanoic acid derivatives
US4241215A (en) Prostane derivatives
NO754195L (fr)
US4045465A (en) Cyanoprostaglandins
NO146280B (no) Bis-tetrahydropyranyleter for anvendelse som mellomprodukt for fremstilling av en fysiologisk aktiv p-bifenylester av en prostaglandinanalog av e- eller f-serien
EP0022443B1 (fr) Carboxamides N-alcoylsulfonylées de 16,16-diméthyl-17-oxaprostaglandines
US4113766A (en) Oxaprostaglandins
CA1087178A (fr) Procede d'obtention de derives des acides 1,3- benzodioxan-prostandiques
CA1085832A (fr) Analogues des prostaglandines
IE47626B1 (en) 15-substituted-w-pentanorprostaglandin derivatives
IE43831B1 (en) Prostane derivatives
US4113723A (en) 15-Substituted-ω-pentanorprostaglandins